The Latest in FDA Evaluations and Research

FDA News


Latest News from FDA News
ATLANTA, GA and WARSAW, POLAND--(Marketwired - August 25, 2014) - Perma-Fix Medical S.A. (WAR: PFM), a subsidiary of Perma-Fix Environmental Services, Inc. (NASDAQ: PESI), and developer of a reliable, cost effective, non-uranium process to produce technetium-99 (Tc-99m), the most widel...
FALLS CHURCH, Va., Aug. 25, 2014 /PRNewswire-iReach/ --
FREDERICK, Md., Aug. 25, 2014 /PRNewswire/ -- Vaccinogen, Inc., (OTC.QB: VGEN) a cancer immunotherapy development company, announced today that it completed the initial closing of a private placement of $80 million of units and common stock.  Vaccinogen received gross proceeds of $10 m...
LOS ANGELES, Aug. 25, 2014 /PRNewswire/ -- NeuroSigma, Inc. (NeuroSigma), a California-based life sciences company focused on commercialization of its non-invasive Monarch™ eTNS™ System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. Depa...
Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its pharmac...
Research and Markets (http://www.researchandmarkets.com/research/thpjfd/navigating) has announced the addition of the "Navigating Through the Maze of In-vitro Diagnostics (IVD) Regulations: A systematic approach From Regulatory Strategy to Regulatory Approva...
Alchemia Limited (ASX: ACL), a drug discovery and development company, announced today the appointment of Ms. Jenni Pilcher as its Chief Financial Officer (CFO). Ms. Pilcher brings extensive financial leadership experience to Alchemia. She is currently the CFO of Mesoblast, where she h...
TARRYTOWN, N.Y. and PARIS, Aug. 25, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, duri...
BASEL, Switzerland, Aug. 24, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) and InterMune, Inc. (NASDAQ: ITMN) today announced they have entered into a definitive merger agreement for Roche to fully acquire InterMune at a price of $74.00 per share in an all-cash transaction.  ...
NEW YORK, NY--(Marketwired - August 23, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in InVivo Therapeutics Holdings Corp. ("InVivo" or the "Company") (OTCQB: NVIV) of the October 6, 2014 deadline to seek the role of lead plaintiff in a federa...
NEW YORK, NY--(Marketwired - August 22, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in EDAP TMS SA ("EDAP" or the "Company") (NASDAQ: EDAP) of the October 3, 2014 deadline to seek the role of lead plaintiff in a federal securities class actio...
LONDON, Aug. 22, 2014 /PRNewswire/ -- ViiV Healthcare announced today that the US Food and Drug Administration (FDA) has approved Triumeq® (abacavir 600mg, dolutegravir 50mg and lamivudine 300mg) tablets for the treatment of HIV-1 infection.1 Triumeq is ViiV Healthcare's first dolutegr...
MobileHelp®, a leader in Mobile Personal Emergency Response System (M-PERS) solutions, today announced it has been ranked number 111 in the 33rd annual Inc. 500|5000, an exclusive ranking of the nation's fastest-growing private companies.
FRANKLIN, Mass., Aug. 22, 2014 /PRNewswire/ -- Arthrosurface, Inc. (www.arthrosurface.com), a developer of novel joint technologies, has received FDA 510(k) clearance for the KISSloc Suture System, a mini plate and suture implant intended for the correction of a Hallux Valgus deformity...
NEW YORK, Aug. 22, 2014 /PRNewswire/ -- Rodale Inc., the world's leading healthy lifestyle company, today announced the launch of Rodale's Organic Life, a relaunch of perennial title Organic Gardening, the first organic magazine and first Rodale title, launched in 1942. The new brand, ...
MobileHelp®, a leader in Mobile Personal Emergency Response System (M-PERS) solutions, today announced the company has been selected as one of fifty leading second-stage companies selected from more than 500 nominations statewide, as this year’s Florida Comp...
LA JOLLA, Cali., Aug. 22, 2014 /PRNewswire/ -- Research presented at the 29th Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human papillomavirus, including the two that cause 70 percent of all cervic...
PITTSBURGH, Aug. 22, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has launched Potassium Chloride Extended-release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg), which is the generic version of Upsher-Smith's Klor-Con®.  Mylan received final approval from the...
Research and Markets (http://www.researchandmarkets.com/research/h8pqvl/computer_system) has announced the addition of the "Computer System Validation - Reduce Costs and Avoid 483s: 2-day In-person Seminar (October)" conference to their offering.
Research and Markets (http://www.researchandmarkets.com/research/lq9pnj/analytical) has announced the addition of the "Analytical Instrument Qualification and System Validation: 2- day In-person Seminar (December)" conference to their offering.
LYNBROOK, N.Y., Aug. 21, 2014 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX® (collagenase clostridium histolyticum or CCH) in the U.S. and XIAPEX® in the EU, today ann...
HOUSTON, Aug. 21, 2014 /PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences.
AUSTIN, Texas, Aug. 21, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed Holly B. Bauzon as Vice President of Sales and Managed Markets.
BOTHELL, Wash. and VANCOUVER, British Columbia, Aug. 21, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Phase 3 ENSPIRIT trial, evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC), is continuing as planned per the re...
DEERFIELD, Ill., Aug. 21, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) reports Baxter International Inc. today announced positive results from its Phase 3 pivotal clinical trial of BAX 855, an investigational, extended half-life recombinant factor VIII (rFVIII) treatment for...
NEW YORK, Aug. 21, 2014 /PRNewswire/ -- Bruckner Oncology has initiated an FDA approved Phase II-III clinical trial which adds Vitamin C to chemotherapy "core" regimens (GFLIO and GFLIO-D)  for patients with locally advanced and metastatic pancreatic cancer (APC).
IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous stromal vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has added Mr. Raymond Hill to its Board...
BROOMFIELD, Colo., Aug. 21, 2014 /PRNewswire/ -- Sherwin-Williams recently presented its esteemed Certified Supplier Award to Ball Corporation (NYSE: BLL) for achieving the highest level of excellence in meeting Sherwin-Williams' Purchasing Center of Excellence Supplier Performance Cri...
Learn about the Effective Use, Analysis, and Best Practices for Collecting eCOA Data in Oncology Programs in a new educational webinar, September 10, 10-11am and 2-3pm EST. The webinar is hosted by PHT Corporation, the leading provider of technologies...
CHICAGO, Aug. 21, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Achil...
CHICAGO, Aug. 21, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Johns...
CHICAGO, Aug. 21, 2014 /PRNewswire/ -- Zacks Equity Research highlights Tata Motors Limited (NYSE:TTM-Free Report) as the Bull of the Day and Tupperware Brands Corporation (NYSE:TUP-Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis onHospira (NYS...
PHILADELPHIA, Aug. 21, 2014 /PRNewswire/ -- ACI Clinical (www.aciclinical.com) announces a new, standards-based platform for independent Data Monitoring Committees.
MolecularHealth announced today an important new component of its TreatmentMAP™ offering in the United States, called MolecularHealth™ RxAssistance. This new service is a value-added benefit for patients and their doctors, providing a level of reimbur...
NEW YORK, August 21, 2014 /PRNewswire/ --
LONDON, August 21, 2014 /PRNewswire/ --
SAN FRANCISCO, Aug. 21, 2014 /PRNewswire/ -- AliveCor, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company clearance for its algorithm to detect atrial fibrillation (AFib), the most common form of cardiac arrhythmia. AliveCor's automated analys...
Core MRI technology provides most advanced scanners for highest intraoperative image quality and best workflow available